Spots Global Cancer Trial Database for adult b acute lymphoblastic leukemia

Every month we try and update this database with for adult b acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation	NCT04626726	Adult B Acute L...	CD19 CAR-T CD22 CAR-T CD19+CD22 CAR-T Fludarabine Cyclophosphamid...	14 Years - 65 Years	Hebei Senlang Biotechnology Inc., Ltd.
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia	NCT02997761	Adult B Acute L... Philadelphia Ch...	Blinatumomab Ibrutinib	18 Years -	University of California, Davis
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	NCT00075725	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Veliparib and Temozolomide in Treating Patients With Acute Leukemia	NCT01139970	Acute Lymphobla... Acute Myeloid L... Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Adult B Acute L... Adult B Acute L... Adult T Acute L... Alkylating Agen... Chronic Myelomo... Recurrent Adult... Recurrent Adult... Secondary Acute...	Laboratory Biom... Pharmacological... Temozolomide Veliparib	18 Years -	National Cancer Institute (NCI)
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)	NCT00866307	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Mercaptopurine Methotrexate Pegaspargase Prednisone Prophylactic Cr... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	NCT00075725	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia	NCT00792948	Acute Lymphobla... Adult B Acute L... Adult B Acute L... Adult L1 Acute ... Adult L2 Acute ... Adult T Acute L... Recurrent Adult...	Allogeneic Hema... Cyclophosphamid... Cytarabine Dasatinib Dexamethasone Doxorubicin Hyd... Etoposide Filgrastim Laboratory Biom... Leucovorin Calc... Methotrexate Methylprednisol... Peripheral Bloo... Prednisone Sirolimus Tacrolimus Total-Body Irra... Vincristine Sul...	18 Years - 60 Years	National Cancer Institute (NCI)
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia	NCT02997761	Adult B Acute L... Philadelphia Ch...	Blinatumomab Ibrutinib	18 Years -	University of California, Davis
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation	NCT04626726	Adult B Acute L...	CD19 CAR-T CD22 CAR-T CD19+CD22 CAR-T Fludarabine Cyclophosphamid...	14 Years - 65 Years	Hebei Senlang Biotechnology Inc., Ltd.
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	NCT00075725	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	Children's Oncology Group
Veliparib and Temozolomide in Treating Patients With Acute Leukemia	NCT01139970	Acute Lymphobla... Acute Myeloid L... Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Adult B Acute L... Adult B Acute L... Adult T Acute L... Alkylating Agen... Chronic Myelomo... Recurrent Adult... Recurrent Adult... Secondary Acute...	Laboratory Biom... Pharmacological... Temozolomide Veliparib	18 Years -	National Cancer Institute (NCI)
Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	NCT02129062	Adult B Acute L... Adult B Acute L... Recurrent Adult...	Ibrutinib Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Veliparib and Temozolomide in Treating Patients With Acute Leukemia	NCT01139970	Acute Lymphobla... Acute Myeloid L... Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Adult B Acute L... Adult B Acute L... Adult T Acute L... Alkylating Agen... Chronic Myelomo... Recurrent Adult... Recurrent Adult... Secondary Acute...	Laboratory Biom... Pharmacological... Temozolomide Veliparib	18 Years -	National Cancer Institute (NCI)
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection	NCT02109224	Adult B Acute L... Chronic Lymphoc... Cutaneous B-Cel... Extranodal Marg... HIV Infection Intraocular Lym... Multicentric An... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Refractory Hair... Refractory Plas... Small Intestina... Splenic Margina... Testicular Lymp... Waldenstrom Mac...	Ibrutinib Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: